Innate immune response Viral respiratory tract infection
Conditions
Interventions
None listed
Sponsors
RSV Research Group van het Wilhelmina Kinderziekenhuis Utrecht, UMCU, onder leiding van Prof. dr. J.L.L. Kimpen, promotor
Eligibility
Age
2 Years to 99 Years
Inclusion criteria
Inclusion criteria: Child = under the age of 13 months (exception:
Exclusion criteria
Exclusion criteria: Child = previous airway morbidity or severe co-morbidity (exception: no exclusion criteria for group 3) Adult = None
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Disease severity: Children: Standardised Respiratory Distress Assessment Instrument (RDAI) Score Elderly: Standardised Adult Physiology And Chronic Health (APACHE) Score, Respiratory Parameter 2. Virological analysis (nasopharyngeal material): Quantitative RT-PCR on RSV, hMPV, rhinovirus, adenovirus, PIV 1-4, Flu A en B, en coronavirus 3. Immunological analysis/cytokine concentrations (nasopharyngeal material): Interferon-alfa using commercial ELISA IL-1aβ/a, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12*70, IL-13, IL-15, IL-17, IL-18, IFN-γ and TNF-a using Luminex 4. Immunological analysis (blood): Leucocytes and differentiation Immunophenotyping Toll-like receptor responses | — |
Countries
Netherlands
Outcome results
None listed